AR and posterior cortical atrophy: Despite understanding these mechanisms, the research and clinical paradigms for treatment of PCa, including CRPC, remain focused on the blockade of the AR-axis signaling, and it is not sufficient to develop CRPC therapeutic strategies [9,10,11].